{"id":49015,"date":"2020-11-12T12:23:54","date_gmt":"2020-11-12T11:23:54","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmj\/?p=49015"},"modified":"2020-11-19T09:42:04","modified_gmt":"2020-11-19T08:42:04","slug":"pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/","title":{"rendered":"Pharma companies must open their books on the funding agreements for covid-19 vaccines"},"content":{"rendered":"<p class=\"standfirst\">Transparency will be important for affordable access to any covid-19 vaccine and it is the responsibility of governments to ensure both, say Manuel Martin and Isabelle Jani-Friend<\/p>\n<p><!--more--><span style=\"font-weight: 400\">Recently, the <em>Financial Times <\/em><\/span><a href=\"https:\/\/www.ft.com\/content\/c474f9e1-8807-4e57-9c79-6f4af145b686\"><span style=\"font-weight: 400\">reported that there is an<\/span><\/a><span style=\"font-weight: 400\"> important limitation to pharmaceutical corporation AstraZeneca\u2019s not-for-profit promises on the production of their covid-19 vaccine. With hundreds of other vaccines under development, supported by an exceptional level of public funding, this is a cause for concern.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Pharmaceutical corporations must open their books, make all funding and licensing agreements public, and substantiate any no-profit claims with data. We know that pharma does not tend to share this information willingly, so it is time for governments to take charge, demand transparency, and put their commitments to equitable access of covid-19 vaccines into action.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">As someone working on innovation and access to healthcare issues for M\u00e9decins Sans Fronti\u00e8res, an international medical humanitarian organisation, and a person living with cystic fibrosis who is at high risk of severe covid-19, we can see how groundbreaking a safe, effective, and affordable covid-19 vaccine would be in our joint global journey towards normality.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">The covid-19 vaccine being co-developed by Oxford University and AstraZeneca was originally discovered by Oxford\u2019s Jenner Institute and has received more than a <\/span><a href=\"https:\/\/www.hhs.gov\/about\/news\/2020\/05\/21\/trump-administration-accelerates-astrazeneca-covid-19-vaccine-to-be-available-beginning-in-october.html\"><span style=\"font-weight: 400\">billion<\/span><\/a> <a href=\"https:\/\/www.ox.ac.uk\/news\/2020-05-18-funding-and-manufacturing-boost-uk-vaccine-programme\"><span style=\"font-weight: 400\">pounds<\/span><\/a><span style=\"font-weight: 400\"> of <\/span><a href=\"https:\/\/cepi.net\/news_cepi\/cepi-partners-with-astrazeneca-to-manufacture-300-million-globally-accessible-doses-of-covid-19-vaccine\/\"><span style=\"font-weight: 400\">public funding<\/span><\/a><span style=\"font-weight: 400\">.\u00a0<\/span><span style=\"font-weight: 400\">When AstraZeneca and Oxford University signed an agreement with one another, they committed to sell the vaccine at a <\/span><a href=\"https:\/\/apnews.com\/article\/virus-outbreak-europe-medication-a1ec6915874850dfd38b062f08d04629\"><span style=\"font-weight: 400\">no-profit price during the pandemic<\/span><\/a><span style=\"font-weight: 400\">, a possible attempt to ward off criticism around their deal. However, in the terms of the deal reported recently by the <\/span><i><span style=\"font-weight: 400\">Financial Times<\/span><\/i><span style=\"font-weight: 400\">, AstraZeneca has apparently given itself the power to declare that the pandemic is over by as soon as July 2021, allowing them to decide what price they charge after this date.<\/span><\/p>\n<p><span style=\"font-weight: 400\">AstraZeneca has said in a statement that \u201cWe continue to operate in that public spirit [of not treating a vaccine as a commercial opportunity] and we will seek expert guidance, including from global organisations, as to when we can say that the pandemic is behind us.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400\">Yet the potential implications of the FT\u2019s report are still huge, especially considering that the vaccine, if proven to be safe and effective, would likely be needed long after the first phases of the pandemic, including for <\/span><a href=\"https:\/\/www.ox.ac.uk\/news\/2020-07-20-new-study-reveals-oxford-coronavirus-vaccine-produces-strong-immune-response\"><span style=\"font-weight: 400\">potential \u201cbooster\u201d shots<\/span><\/a><span style=\"font-weight: 400\">. If it came to pass, it would mean that, after July 2021, AstraZeneca could charge the NHS and other health systems around the world high prices for a vaccine that has received huge investments of public money. This does not surprise us. Decades of experience has shown us that pharmaceutical corporations often do not resist the opportunity to maximise their profits.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">M\u00e9decins Sans Fronti\u00e8res works with patients in over 70 countries around the world, including responding to the pandemic in nearly 60 of these countries. MSF has seen firsthand the effect of high prices and monopolies held by pharmaceutical corporations, hindering the introduction of affordable versions of pneumonia and human papillomavirus vaccines in developing countries. If pharmaceutical corporations continue with \u201cbusiness as usual\u201d tactics and charge exorbitant prices, overwhelmed health systems could be pushed to their breaking point, with dire consequences for the health of people around the world.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">The community of people living with cystic fibrosis in the UK fought for five years to gain access to a life changing medicine to treat the disease after pharmaceutical corporation <\/span><a href=\"https:\/\/www.bmj.com\/content\/364\/bmj.l1094\"><span style=\"font-weight: 400\">Vertex launched a drug<\/span><\/a><span style=\"font-weight: 400\"> at a price that the NHS simply could not afford. As we anxiously wait for an effective covid-19 vaccine, we cannot allow history to repeat itself. If future covid-19 vaccines are unaffordable and inaccessible, people around the world at the highest risk of severe covid-19, like people with cystic fibrosis, would again be forced to pick up the fight for access.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">The global community is desperately searching for a way out of this pandemic. Billions of pounds of public money are flowing into the research and development of covid-19 vaccines around the world. And despite the millions of lives hanging in the balance, this money continues to be handed over to the pharmaceutical industry through confidential deals without any transparency. This needs to stop. Transparency is a catalyst for affordable access to all health tools and it is the responsibility of governments to ensure both.<\/span><\/p>\n<p><span style=\"font-weight: 400\">The covid-19 pandemic is an unprecedented situation that demands unprecedented measures. If governments are truly committed to ensuring equitable access to covid-19 vaccines for the world, they must put people first and force pharmaceutical corporations to open their books. During a pandemic, more lives than ever rest on transparency.<\/span><\/p>\n<p><b><i>Manuel Martin<\/i><\/b><i><span style=\"font-weight: 400\"> is a medical innovation and access policy adviser for the M\u00e9decins Sans Fronti\u00e8res Access Campaign. Twitter <a href=\"https:\/\/twitter.com\/LeaozinhoM\">@LeaozinhoM<\/a><\/span><\/i><\/p>\n<p><b>Competing interests: <\/b><span style=\"font-weight: 400\">Manuel Martin is an employee of the Doctors Without Borders \/ M\u00e9dicines Sans Frontiers Access Campaign. No other competing interests.<\/span><\/p>\n<p><b><i>Isabelle Jani-Friend<\/i><\/b><i><span style=\"font-weight: 400\"> is a freelance journalist and a patient leader for Just Treatment.\u00a0<\/span><\/i><\/p>\n<p><b>Competing interests: <\/b><span style=\"font-weight: 400\">Nothing further to declare.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Transparency will be important for affordable access to any covid-19 vaccine and it is the responsibility of governments to ensure both, say Manuel Martin and Isabelle Jani-Friend [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/\">More&#8230;<\/a><\/p>\n","protected":false},"author":419,"featured_media":49017,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[750],"tags":[],"class_list":["post-49015","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-msf"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharma companies must open their books on the funding agreements for covid-19 vaccines - The BMJ<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma companies must open their books on the funding agreements for covid-19 vaccines - The BMJ\" \/>\n<meta property=\"og:description\" content=\"Transparency will be important for affordable access to any covid-19 vaccine and it is the responsibility of governments to ensure both, say Manuel Martin and Isabelle Jani-Friend [...]More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/\" \/>\n<meta property=\"og:site_name\" content=\"The BMJ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bmjdotcom\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T11:23:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-19T08:42:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/bmj\/files\/2020\/11\/coronavirus_vaccine_trial_south_africa_GettyImages-1223516524.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"540\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"kellybrendel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:site\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"kellybrendel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2020\\\/11\\\/12\\\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2020\\\/11\\\/12\\\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\\\/\"},\"author\":{\"name\":\"kellybrendel\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/d634d72476ce60014b19ed2db4ae3760\"},\"headline\":\"Pharma companies must open their books on the funding agreements for covid-19 vaccines\",\"datePublished\":\"2020-11-12T11:23:54+00:00\",\"dateModified\":\"2020-11-19T08:42:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2020\\\/11\\\/12\\\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\\\/\"},\"wordCount\":829,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2020\\\/11\\\/12\\\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2020\\\/11\\\/coronavirus_vaccine_trial_south_africa_GettyImages-1223516524.jpg\",\"articleSection\":[\"MSF\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2020\\\/11\\\/12\\\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2020\\\/11\\\/12\\\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2020\\\/11\\\/12\\\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\\\/\",\"name\":\"Pharma companies must open their books on the funding agreements for covid-19 vaccines - The BMJ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2020\\\/11\\\/12\\\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2020\\\/11\\\/12\\\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2020\\\/11\\\/coronavirus_vaccine_trial_south_africa_GettyImages-1223516524.jpg\",\"datePublished\":\"2020-11-12T11:23:54+00:00\",\"dateModified\":\"2020-11-19T08:42:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2020\\\/11\\\/12\\\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2020\\\/11\\\/12\\\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2020\\\/11\\\/12\\\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2020\\\/11\\\/coronavirus_vaccine_trial_south_africa_GettyImages-1223516524.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2020\\\/11\\\/coronavirus_vaccine_trial_south_africa_GettyImages-1223516524.jpg\",\"width\":540,\"height\":350,\"caption\":\"SOWETO, SOUTH AFRICA - JUNE 26: A volunteer receives an injection from a medical worker during the country's first human clinical trial for a potential vaccine against COVID-19 at the Baragwanath Hospital on June 28, 2020 in Soweto, South Africa. It is reported that Africa's first COVID-19 vaccine trial began on June 24 in South Africa. The vaccine, developed by Oxford University's (UK) Jenner Institute, will inoculate two thousand South Africans. (Photo by Felix Dlangamandla\\\/Beeld\\\/Gallo Images via Getty Images)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2020\\\/11\\\/12\\\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma companies must open their books on the funding agreements for covid-19 vaccines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"name\":\"The BMJ\",\"description\":\"Helping doctors make better decisions.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\",\"name\":\"The BMJ\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"width\":852,\"height\":568,\"caption\":\"The BMJ\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bmjdotcom\\\/\",\"https:\\\/\\\/x.com\\\/bmj_latest\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/d634d72476ce60014b19ed2db4ae3760\",\"name\":\"kellybrendel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4e35f22486ccca5430679be45c0b31ada51650038ef38f08b0d342bd1af4c377?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4e35f22486ccca5430679be45c0b31ada51650038ef38f08b0d342bd1af4c377?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4e35f22486ccca5430679be45c0b31ada51650038ef38f08b0d342bd1af4c377?s=96&d=mm&r=g\",\"caption\":\"kellybrendel\"},\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/author\\\/kellybrendel\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharma companies must open their books on the funding agreements for covid-19 vaccines - The BMJ","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/","og_locale":"en_US","og_type":"article","og_title":"Pharma companies must open their books on the funding agreements for covid-19 vaccines - The BMJ","og_description":"Transparency will be important for affordable access to any covid-19 vaccine and it is the responsibility of governments to ensure both, say Manuel Martin and Isabelle Jani-Friend [...]More...","og_url":"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/","og_site_name":"The BMJ","article_publisher":"https:\/\/www.facebook.com\/bmjdotcom\/","article_published_time":"2020-11-12T11:23:54+00:00","article_modified_time":"2020-11-19T08:42:04+00:00","og_image":[{"width":540,"height":350,"url":"https:\/\/blogs.bmj.com\/bmj\/files\/2020\/11\/coronavirus_vaccine_trial_south_africa_GettyImages-1223516524.jpg","type":"image\/jpeg"}],"author":"kellybrendel","twitter_card":"summary_large_image","twitter_creator":"@bmj_latest","twitter_site":"@bmj_latest","twitter_misc":{"Written by":"kellybrendel","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/"},"author":{"name":"kellybrendel","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/d634d72476ce60014b19ed2db4ae3760"},"headline":"Pharma companies must open their books on the funding agreements for covid-19 vaccines","datePublished":"2020-11-12T11:23:54+00:00","dateModified":"2020-11-19T08:42:04+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/"},"wordCount":829,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2020\/11\/coronavirus_vaccine_trial_south_africa_GettyImages-1223516524.jpg","articleSection":["MSF"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/","url":"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/","name":"Pharma companies must open their books on the funding agreements for covid-19 vaccines - The BMJ","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2020\/11\/coronavirus_vaccine_trial_south_africa_GettyImages-1223516524.jpg","datePublished":"2020-11-12T11:23:54+00:00","dateModified":"2020-11-19T08:42:04+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/#primaryimage","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2020\/11\/coronavirus_vaccine_trial_south_africa_GettyImages-1223516524.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2020\/11\/coronavirus_vaccine_trial_south_africa_GettyImages-1223516524.jpg","width":540,"height":350,"caption":"SOWETO, SOUTH AFRICA - JUNE 26: A volunteer receives an injection from a medical worker during the country's first human clinical trial for a potential vaccine against COVID-19 at the Baragwanath Hospital on June 28, 2020 in Soweto, South Africa. It is reported that Africa's first COVID-19 vaccine trial began on June 24 in South Africa. The vaccine, developed by Oxford University's (UK) Jenner Institute, will inoculate two thousand South Africans. (Photo by Felix Dlangamandla\/Beeld\/Gallo Images via Getty Images)"},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmj\/2020\/11\/12\/pharma-companies-must-open-their-books-on-the-funding-agreements-for-covid-19-vaccine-candidates\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmj\/"},{"@type":"ListItem","position":2,"name":"Pharma companies must open their books on the funding agreements for covid-19 vaccines"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmj\/#website","url":"https:\/\/blogs.bmj.com\/bmj\/","name":"The BMJ","description":"Helping doctors make better decisions.","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmj\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmj\/#organization","name":"The BMJ","url":"https:\/\/blogs.bmj.com\/bmj\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","width":852,"height":568,"caption":"The BMJ"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bmjdotcom\/","https:\/\/x.com\/bmj_latest"]},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/d634d72476ce60014b19ed2db4ae3760","name":"kellybrendel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4e35f22486ccca5430679be45c0b31ada51650038ef38f08b0d342bd1af4c377?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4e35f22486ccca5430679be45c0b31ada51650038ef38f08b0d342bd1af4c377?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4e35f22486ccca5430679be45c0b31ada51650038ef38f08b0d342bd1af4c377?s=96&d=mm&r=g","caption":"kellybrendel"},"url":"https:\/\/blogs.bmj.com\/bmj\/author\/kellybrendel\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/49015","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/users\/419"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/comments?post=49015"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/49015\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media\/49017"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media?parent=49015"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/categories?post=49015"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/tags?post=49015"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}